Skip to content
  • Home
  • Subscribe to email list

Pharminent

  • Home
  • Subscribe to email list
Company August 22, 2016August 26, 2016

Pfizer Eyes Purchase Of Medivation To Add Cancer Drugs To Portfolio

Pfizer To Buy Medivation To Add Cancer Drugs To Portfolio

Post navigation

← Previous Post

Lilly and AstraZeneca Receive FDA Fast Track Designation for AZD3293, an Investigational Treatment for Early Alzheimer’s Disease

Next Post →

Anti-TNFs Well Tolerated in Older RA Patients (CME/CE)

Categories
RSS Emerging Markets
  • Chinese R&D sector takes ‘significant step’ as outsourcing demand increases December 7, 2017
  • Six factors shaping healthcare in emerging markets October 10, 2017
  • How Startups Are Trying To Overcome India’s Healthcare Challenges September 25, 2017
  • Trovagene Announces Agreement with Novogene for NextCollect™ in China July 12, 2017
  • China FDA changes will speed up approval process, says CRO June 7, 2017
  • India’s drugmakers need more time to meet international standards: industry group May 17, 2017
  • Generic consistency evaluation in China: the coming paradigm shift in drug pricing and patent cliff April 19, 2017
RSS Biosimilar
  • AbbVie, Samsung Bioepis in deal; Humira biosimilar U.S. release in 2023 April 5, 2018
  • Mundipharma inks third biosimilar deal with Celltrion March 21, 2018
  • Industry touts savings potential of generics and biosimilars February 14, 2018
  • Biogen looking to up its stake in Samsung biosimilar JV February 1, 2018
  • Sandoz announces exclusive global collaboration with Biocon on next-generation biosimilars January 18, 2018
  • Lucentis biosimilar: Formycon eyes 2020 for US launch November 28, 2017
  • Five more biosimilar-free years for AbbVie’s Humira September 28, 2017
RSS Pricing
  • Hospitals To Be Required To Post Prices Online As Part Of CMS Push To Increase Transparency April 25, 2018
  • Pricing and Market Access Outlook 2018 March 5, 2018
  • Roche hemophilia drug lowers costs despite high price: ICER January 27, 2018
  • Payers point to Spark’s gene therapy as a model for innovative pricing plans January 12, 2018
  • FDA eyes even more pricing competition with another round of generics moves November 14, 2017
  • New Infographic: A Response to “A Better Deal” on Drug Pricing September 21, 2017
  • On Drug Pricing: FDA Backs Up Its Calls for Increased Competition August 21, 2017
RSS Payer
  • How Pharma Can Help Patients Feel Less Overwhelmed When Dealing with Payers April 20, 2018
  • Perspectives: CMS Takes Steps to Ensure Patients Benefit From Negotiated Discounts February 7, 2018
  • CMS Considers Alternate Payment Models To Curb Costs On High-Price Treatments, Gene Therapy December 1, 2017
  • Novartis’ CAR-T drug needs new payment model, says Express Scripts September 25, 2017
  • Op-Ed: Why single-payer health-care could be closer than you think June 26, 2017
RSS Marketing
  • AstraZeneca at Cannes: Healthcare delivery’s speeding away from pharma’s marketing model June 26, 2017
  • What marketers need to know about tax reform, off-label promotion, pricing May 17, 2017
  • The Impact of AI and Machine Learning in Marketing February 27, 2017
RSS R&D
  • Creating a connected ecosystem to gain insights across R&D May 15, 2018
  • Commercial Trends Forecast: ‘R&D is transforming into R&D&C’ March 13, 2018
  • Eliminating Silos: Dismantling the Frankenstein of Clinical R&D March 5, 2018
RSS Company News
  • Novartis forges forward into digital pharma with FocalView app April 25, 2018
  • Sandoz, Pear to commercialize prescription digital therapeutics April 19, 2018
  • As Novartis Buys Into Gene Therapy, GSK Bows Out With Orchard Deal April 12, 2018
  • AstraZeneca licenses Ionis’ clinical-phase antisense NASH drug April 9, 2018
  • Novartis scaling ‘site-less’ trials through expanded Science 37 alliance March 7, 2018
  • AstraZeneca spins out new biotech, shedding autoimmune drugs February 28, 2018
  • Alphabet-backed Flatiron Health is being acquired by Roche February 15, 2018
RSS Immunotherapy
  • Janssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimens May 2, 2018
  • MSD’s Keytruda bags another trial success in NSCLC April 10, 2018
  • FDA Expands Bristol-Myers Squibb’s Opdivo Dosing Schedule March 6, 2018
  • BMS, Nektar to jointly develop, commercialise immunotherapy combo February 15, 2018
  • ASH 2017: CAR-T therapy and beyond December 6, 2017
  • 4 Ways To Market CAR-T Therapies October 16, 2017
  • AstraZeneca, NewLink pen PD-L1 and IDO combination pact September 25, 2017
RSS Cardiovascular
  • Regeneron/Sanofi to cut price of heart drug in Express Scripts deal May 1, 2018
  • Amgen gets prevention claim for cholesterol drug Repatha December 4, 2017
  • AstraZeneca outlicenses Brilinta reversal agent November 28, 2017
  • EU OKs low-dose Xarelto to prevent recurrent VTE November 2, 2017
  • AstraZeneca touts Brilinta CV benefit with new analysis August 24, 2017
  • Merck, Novartis pipeline stunners headline surprisingly good month for CV agents June 28, 2017
  • Novartis heart drug success opens up new care option June 22, 2017
RSS Diabetes
  • Software That Uses Artificial Intelligence To Screen Eyes For Diabetes Damage Approved By FDA April 13, 2018
  • Boehringer Ingelheim and Lilly expand heart failure program for Jardiance® with new exercise capacity trials March 6, 2018
  • Boehringer strikes Jardiance outcomes deal with Prime PBM January 31, 2018
  • Lilly partners with Rimidi on digital diabetes management tool December 15, 2017
  • One Drop and Fitbit to integrate diabetes and activity data November 1, 2017
  • Fitbit and Dexcom to bring diabetes data to Ionic smartwatch September 8, 2017
  • Diabetes drugmakers partner with mobile startups to boost patient engagement July 20, 2017
RSS Alzheimer’s
  • AbbVie, Voyager set sights on ‘one-time’ Alzheimer’s treatment February 20, 2018
  • AbbVie, Alector to develop novel treatments for Alzheimer’s disease October 25, 2017
  • Assessing The Pipeline For Alzheimer’s Disease (Part I: Anti-Amyloid Antibodies) October 13, 2017
  • Biogen’s Alzheimer’s Hope Tops The Sector’s Most Valuable Pipeline Projects August 16, 2017
  • New Gene Discoveries Could Redefine Alzheimer’s Treatment July 21, 2017
Create a website or blog at WordPress.com